PubMed Health⌕ Search

PubMed · 16435607

[Factor VIII hyperactivity: an arterio-venous thrombogenic factor. Case report].

Abstract

Thrombosis is the principal mechanism in vascular pathology, whether cerebral, coronary or peripheral. During the initial stages of infarction, coagulation contributes to vascular occlusion, the haemostatic factors playing a determining role in the development of atherothrombotic lesions. An increase in a coagulation protein, besides any lowering of anticoagulation protein levels, is a risk factor for thrombosis. Among these pro-coagulant factors, the pro-thrombogenic action of factor VIII has without doubt been studied the least. We report the case of a 62 year old patient with a personal and family history of many previous thrombotic episodes, both arterial and venous, in whom factor VIII hyperactivity was discovered after a myocardial infarction. This case underlines the association of the factor VIII complex with thrombosis, and its clinical repercussions, especially the incidence of coronary pathology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S L Bennani, B Vaquette, D Pavin, D Boulmier, J C Daubert, P Mabo. 2005. [Factor VIII hyperactivity: an arterio-venous thrombogenic factor. Case report].. https://pubmed.ncbi.nlm.nih.gov/16435607/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Two- and three-dimensional echocardiographic imaging of massive left intraventricular thrombosis complicating fatal heart failure.

These images describe a case of massive left ventricular (LV) thrombosis complicating fatal heart failure in a 61 year-old patient with history of myocardial infarction, apical aneurysm, and no previous evidence of LV thrombosis. Two-dimensional echocardiography showed that the thrombus obliterated 34% of LV volume at end-diastole. Three-dimensional echocardiography allowed higher definition of thrombus architecture and dimensions, revealing obliteration of 40% of LV volume at end-diastole. Careful assessment of thromboembolic risk to guide therapeutic decision making should be considered mandatory in subjects with a large extent of wall asynergy, even in those with no previous evidence of LV thrombosis. Three-dimensional echocardiography may be considered an accurate technique for the characterization of LV thrombi in these patients.

Coronary Thrombosis↗

Simultaneous multivessel acute drug-eluting stent thrombosis.

Stent thrombosis (ST) in the era of bare metal stents (BMS) using high-pressure stent deployment and combined anti-platelet therapy is an uncommon but feared complication. There is concern for an elevated risk of stent thrombosis (ST) with drug-eluting stents (DES). We describe a case of simultaneous multivessel drug-eluting stent thrombosis 8 h after deployment of paclitaxel-eluting stents in the right coronary (RCA) and left anterior descending (LAD) arteries.

Coronary Thrombosis↗